Advertisement

Suggestions

Cancer

Proton therapy - Radiotherapy
···········

Proton vs. Photon Showdown: PARTIQoL Finds a Surprise Tie in Prostate Cancer Quality of Life – What It Really Means for Patients and Clinicians

PARTIQoL and the state of prostate cancer QOL research Why PARTIQoL matters Localized prostate cancer is common and, for most men, highly curable—which puts quality of life on equal footing with cancer control when choosing among effective treatments. PARTIQoL was explicitly designed
September 30, 2025
PSMAI maging & Therapy
···················

PSMA I&T: The Next Game-Changer in Prostate Cancer Imaging & Therapy

Clinical Applications: Imaging and Therapy PSMA I&T is being used for both prostate cancer PET imaging and radioligand therapy (RLT). In diagnostic imaging, ^68Ga-PSMA I&T PET/CT has been applied to stage newly diagnosed prostate cancer. In one study of 82 men with
September 28, 2025
AlphaFold 3
··················

AlphaFold 3 Unleashed: Revolutionary AI Decodes DNA, RNA and Proteins to Supercharge Drug Discovery

What is AlphaFold 3 and How It Differs from AlphaFold 2 AlphaFold 3 is the latest generation of DeepMind’s AI for molecular structure prediction. Like AlphaFold 2, it takes genetic or molecular sequences as input and predicts 3D shapes. The key difference
September 21, 2025
Proton Therapy
···············

Proton Therapy Breakthroughs 2025: Cutting-Edge Cancer Treatment Promises Fewer Side Effects, New Hope

Proton therapy is an advanced form of radiation treatment that is rapidly gaining attention for its precision and potential to spare healthy tissues. Unlike traditional X-ray (photon) therapy, proton therapy uses beams of accelerated protons that stop directly in tumors, minimizing collateral
September 17, 2025
Radioligand Therapy
·····················

New Cancer Treatment – Why Experts Say Radioligand Therapy Is a Game-Changer

What Is Radioligand Therapy? Mechanism of Action Radioligand therapy is a targeted radiotherapy approach. A therapeutic agent is made of a radioactive isotope (emitting beta or alpha particles) linked to a ligand that binds a molecule on cancer cells siemens-healthineers.com, healthsystemreadiness.com. For example, lutetium-177 dotatate attaches to somatostatin receptors on neuroendocrine tumors,
September 15, 2025
Cancer Vaccines
·······················

The Race for Personalized mRNA Cancer Vaccines: Phase 3 Trials Aim to Transform Melanoma and Lung Cancer Treatment

Key Facts Global Phase 3 Trials: Melanoma Leads the Way The first personalized mRNA cancer vaccine to reach Phase 3 is Moderna’s mRNA-4157 (V940) in melanoma – a groundbreaking collaboration with Merck that has quickly become a bellwether for the field. Melanoma
September 13, 2025